JP6029670B2 - アセトアミノフェンコンジュゲートおよびその組成物ならびにその使用方法 - Google Patents

アセトアミノフェンコンジュゲートおよびその組成物ならびにその使用方法 Download PDF

Info

Publication number
JP6029670B2
JP6029670B2 JP2014532014A JP2014532014A JP6029670B2 JP 6029670 B2 JP6029670 B2 JP 6029670B2 JP 2014532014 A JP2014532014 A JP 2014532014A JP 2014532014 A JP2014532014 A JP 2014532014A JP 6029670 B2 JP6029670 B2 JP 6029670B2
Authority
JP
Japan
Prior art keywords
acetaminophen
compound
conjugate
individual
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2014532014A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014530204A5 (en:Method
JP2014530204A (ja
Inventor
キース アール． ブレー，
キース アール． ブレー，
ベルンド ジャンデレイト，
ベルンド ジャンデレイト，
Original Assignee
アコーダ セラピューティクス、インク．
アコーダ セラピューティクス、インク．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アコーダ セラピューティクス、インク．, アコーダ セラピューティクス、インク． filed Critical アコーダ セラピューティクス、インク．
Publication of JP2014530204A publication Critical patent/JP2014530204A/ja
Publication of JP2014530204A5 publication Critical patent/JP2014530204A5/ja
Application granted granted Critical
Publication of JP6029670B2 publication Critical patent/JP6029670B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
    • C07C329/02—Monothiocarbonic acids; Derivatives thereof
    • C07C329/04—Esters of monothiocarbonic acids
    • C07C329/06—Esters of monothiocarbonic acids having sulfur atoms of thiocarbonic groups bound to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C313/02—Sulfinic acids; Derivatives thereof
    • C07C313/04—Sulfinic acids; Esters thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2014532014A 2011-09-22 2012-09-21 アセトアミノフェンコンジュゲートおよびその組成物ならびにその使用方法 Expired - Fee Related JP6029670B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161538075P 2011-09-22 2011-09-22
US61/538,075 2011-09-22
PCT/US2012/056625 WO2013044064A1 (en) 2011-09-22 2012-09-21 Acetaminophen conjugates, compositions and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016204398A Division JP2017019859A (ja) 2011-09-22 2016-10-18 アセトアミノフェンコンジュゲートおよびその組成物ならびにその使用方法

Publications (3)

Publication Number Publication Date
JP2014530204A JP2014530204A (ja) 2014-11-17
JP2014530204A5 JP2014530204A5 (en:Method) 2015-11-12
JP6029670B2 true JP6029670B2 (ja) 2016-11-24

Family

ID=47914904

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2014532014A Expired - Fee Related JP6029670B2 (ja) 2011-09-22 2012-09-21 アセトアミノフェンコンジュゲートおよびその組成物ならびにその使用方法
JP2016204398A Withdrawn JP2017019859A (ja) 2011-09-22 2016-10-18 アセトアミノフェンコンジュゲートおよびその組成物ならびにその使用方法
JP2018067394A Withdrawn JP2018131447A (ja) 2011-09-22 2018-03-30 アセトアミノフェンコンジュゲートおよびその組成物ならびにその使用方法
JP2020081769A Withdrawn JP2020122010A (ja) 2011-09-22 2020-05-07 アセトアミノフェンコンジュゲートおよびその組成物ならびにその使用方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2016204398A Withdrawn JP2017019859A (ja) 2011-09-22 2016-10-18 アセトアミノフェンコンジュゲートおよびその組成物ならびにその使用方法
JP2018067394A Withdrawn JP2018131447A (ja) 2011-09-22 2018-03-30 アセトアミノフェンコンジュゲートおよびその組成物ならびにその使用方法
JP2020081769A Withdrawn JP2020122010A (ja) 2011-09-22 2020-05-07 アセトアミノフェンコンジュゲートおよびその組成物ならびにその使用方法

Country Status (7)

Country Link
US (1) US9024055B2 (en:Method)
EP (1) EP2758133A4 (en:Method)
JP (4) JP6029670B2 (en:Method)
AU (1) AU2012312136B2 (en:Method)
CA (1) CA2849731C (en:Method)
HK (1) HK1200392A1 (en:Method)
WO (1) WO2013044064A1 (en:Method)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5757864B2 (ja) 2008-05-20 2015-08-05 ニューロジェシックス， インコーポレイテッド 水溶性アセトアミノフェン類似体
KR101677126B1 (ko) 2008-05-20 2016-11-22 노이로제스엑스, 인코포레이티드 탄산염 프로드러그 및 그것의 사용 방법
JP7156154B2 (ja) * 2019-04-18 2022-10-19 株式会社島津製作所 培地処理システム及び培地処理方法
EP3979999A4 (en) * 2019-06-04 2023-07-26 Lennham Pharmaceuticals, Inc. Deuterated forms of acetaminophen and uses thereof
CN113248596B (zh) * 2021-04-15 2022-12-16 华南农业大学 一种可同时检测对乙酰氨基酚和非那西丁的人工抗原、抗体及其制备方法和应用
CN116239486B (zh) * 2023-03-16 2025-07-08 梯尔希（南京）药物研发有限公司 一种对乙酰氨基酚杂质的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2444043A1 (fr) 1978-12-15 1980-07-11 Bottu Nouveau derive du paracetamol, son procede de preparation et son utilisation en therapeutique
US5985856A (en) 1997-12-31 1999-11-16 University Of Kansas Water soluble prodrugs of secondary and tertiary amine containing drugs and methods of making thereof
US6204257B1 (en) 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
JP2010511717A (ja) 2006-12-05 2010-04-15 ニューロジェシックス， インコーポレイテッド プロドラッグおよびその作成ならびに使用方法
JP5757864B2 (ja) 2008-05-20 2015-08-05 ニューロジェシックス， インコーポレイテッド 水溶性アセトアミノフェン類似体
KR101677126B1 (ko) * 2008-05-20 2016-11-22 노이로제스엑스, 인코포레이티드 탄산염 프로드러그 및 그것의 사용 방법
BRPI0912820A2 (pt) 2008-05-20 2015-10-13 Neurogesx Inc pró-fármacos de relação hepatoprotetora de acetaminofeno
US8569466B2 (en) * 2008-09-10 2013-10-29 Nnochiri Ekwuribe Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancers
JP2012520342A (ja) * 2009-03-16 2012-09-06 ジェンメディカ・セラピューティックス・ソシエダッド・リミターダ 代謝障害を処置するのに有用な抗炎症剤および抗酸化剤のコンジュゲート

Also Published As

Publication number Publication date
EP2758133A4 (en) 2015-05-27
AU2012312136B2 (en) 2017-06-29
CA2849731A1 (en) 2013-03-28
JP2020122010A (ja) 2020-08-13
HK1200392A1 (en) 2015-08-07
CA2849731C (en) 2020-01-14
AU2012312136A1 (en) 2014-04-17
US20140243407A1 (en) 2014-08-28
WO2013044064A1 (en) 2013-03-28
JP2017019859A (ja) 2017-01-26
EP2758133A1 (en) 2014-07-30
US9024055B2 (en) 2015-05-05
JP2018131447A (ja) 2018-08-23
JP2014530204A (ja) 2014-11-17

Similar Documents

Publication Publication Date Title
JP2018131447A (ja) アセトアミノフェンコンジュゲートおよびその組成物ならびにその使用方法
JP6063072B2 (ja) 水溶性アセトアミノフェン類似体
JP2021036001A (ja) 肝保護剤アセトアミノフェンミューチュアルプロドラッグ
US8236985B2 (en) Compounds and uses thereof
CN101506143A (zh) 具有快速皮肤穿透速度的带正电荷的水溶性的对乙酰氨基酚及其相关化合物的前药
WO2011153374A1 (en) Prodrugs of azacitidine 5'-phosphate
JP2007510737A (ja) 癌処置のためのセラミド異化阻害剤としてのｐｐｍｐ
CN103037842B (zh) 药物化合物
US20160362402A1 (en) Novel compounds having anti-allodynic and antihyperalgesic activity
HK1160792A (en) Hepatoprotectant acetaminophen mutual prodrugs

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150918

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150918

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160520

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160519

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160819

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160920

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20161018

R150 Certificate of patent or registration of utility model

Ref document number: 6029670

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees